Stock Price Quote

PARMAX PHARMA LTD.

NSE : NABSE : 540359ISIN CODE : INE240T01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE47.37-0.12 (-0.25 %)
PREV CLOSE ( ) 47.49
OPEN PRICE ( ) 46.54
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1385
TODAY'S LOW / HIGH ( )46.54 48.98
52 WK LOW / HIGH ( ) 25.0355.02
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-11 1994
Management Info
- Chairman Umang A Gosalia - Managing Director
Registered Office

Address Plot No. 20, Survey No. 52,8 B - Rajkot - Gondal National Highway No 27,Hadamtala, Tal. Kotda Sangani,
Rajkot,
Gujarat-360311

Phone 02827–270534 / 270535

Email info@parmaxpharma.com

Website www.parmaxpharma.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE

NEWS

21Apr Parmax Pharma informs about compliance
Parmax Pharma has informed that it enclosed the Compliance Certificate f..
30Oct Parmax Pharma informs about certificate
Parmax Pharma has informed that it enclosed a Certificate dated 3rd Octo..
17Jun Parmax Pharma informs about details of
Parmax Pharma has informed about intimation regarding loss of share cert..
17Jun Parmax Pharma informs about details of
Parmax Pharma has informed about intimation regarding loss of share cert..
06Jun Parmax Pharma informs about loss of sh
Parmax Pharma has informed regarding loss of share certificate under Reg..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit-3.94-57.52
Gross Profit -3.94 -56.57
Operating Profit 1.21-33.23
Net Sales 62.84110.53

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  6314.35 (4.50%)
M.Cap ( in Cr)14542.34
Alkem Laboratories (BSE)
peergroup  5290.35 (3.18%)
M.Cap ( in Cr)63254.07
Blue Jet Healthcare (BSE)
peergroup  837.55 (8.73%)
M.Cap ( in Cr)14528.60
NGL Fine-Chem (BSE)
peergroup  1207.50 (5.00%)
M.Cap ( in Cr)746.00
Pfizer (BSE)
peergroup  4456.25 (1.26%)
M.Cap ( in Cr)20386.33

Shareholding Pattern

NON-INSTITUTION 69.2%
PROMOTERS 30.8%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Parmax Pharma Ltd.

Parmax Pharma Ltd. was incorporated in the year 1994. Its today's share price is 47.37. Its current market capitalisation stands at Rs 17.72 Cr. In the latest quarter, company has reported Gross Sales of Rs. 110.53 Cr and Total Income of Rs.110.7 Cr. The company's management includes Bhakti Aghera, Ami R Shah, Nikhil Uchat, Umang A Gosalia.

It is listed on the BSE with a BSE Code of 540359 , NSE with an NSE Symbol of and ISIN of INE240T01014. It's Registered office is at Plot No. 20, Survey No. 52,8 B - Rajkot - Gondal National Highway No 27,Hadamtala, Tal. Kotda SanganiRajkot-360311, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BA Shah Associates, BA Shah SR Mehta & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.